Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Trifluoroescaline

From Wikipedia, the free encyclopedia

Pharmaceutical compound
Trifluoroescaline
Clinical data
Other namesTFE; 3,3,3-Trifluoroescaline; 3,3,3-TFE; F3EM; 4-(2,2,2-Trifluoroethoxy)-3,5-dimethoxyphenethylamine; 3,5-Dimethoxy-4-(2,2,2-trifluoroethoxy)phenethylamine
Routes of
administration
Oral[1][2][3]
Drug classSerotonin receptor modulator;Serotonin5-HT2A receptoragonist;Serotonergic psychedelic;Hallucinogen
ATC code
  • None
Pharmacokinetic data
Duration of action12–18 hours[1][2][3]
Identifiers
  • 2-[3,5-dimethoxy-4-(2,2,2-trifluoroethoxy)phenyl]ethanamine
CAS Number
PubChemCID
ChemSpider
Chemical and physical data
FormulaC12H16F3NO3
Molar mass279.259 g·mol−1
3D model (JSmol)
  • COC1=CC(=CC(=C1OCC(F)(F)F)OC)CCN
  • InChI=1S/C12H16F3NO3/c1-17-9-5-8(3-4-16)6-10(18-2)11(9)19-7-12(13,14)15/h5-6H,3-4,7,16H2,1-2H3
  • Key:LMULYKOEWFMASK-UHFFFAOYSA-N

Trifluoroescaline (TFE), also known as4-(2,2,2-trifluoroethoxy)-3,5-dimethoxyphenethylamine, is apsychedelic drug of thephenethylamine andscaline families related tomescaline.[1][2][3] It is atrifluorinatedderivative ofescaline.[1][2][3] The drug has a dose range of 35 to 65 mgorally and aduration of 12 to 18 hours.[1][2][3] It has similarpotency to escaline, greatly increased potency relative to mescaline, and a prolonged duration compared to both mescaline and escaline.[1][2][3] The effects of trifluoroescaline have been reported to include enhancedfantasy, strongclosed-eye visuals, significantopen-eye visuals, and lowbody load.[1] The drug is a low-potencypartial agonist of theserotonin5-HT2A receptor and also interacts with otherserotonin receptors andtargets.[3] Thechemical synthesis of trifluoroescaline has been described.[4] Trifluoroescaline was first described in thescientific literature byDaniel Trachsel in 2002.[1][2][3][4] Itspharmacology was studied in more detail in 2021.[3]

See also

[edit]

References

[edit]
  1. ^abcdefghTrachsel D, Lehmann D, Enzensperger C (2013).Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag. pp. 706,710–711, 717,736–737.ISBN 978-3-03788-700-4.OCLC 858805226.
  2. ^abcdefgTrachsel D (2012). "Fluorine in psychedelic phenethylamines".Drug Testing and Analysis.4 (7–8):577–590.doi:10.1002/dta.413.PMID 22374819.s. Difluoroescaline (77), on the other hand, retained, and trifluoroescaline (78) showed increased human potency of escaline (70). [...] The trifluoroethyl derivative 78 (35–65 mg, 12–18 h) proved to be a psychedelic compound of similar or slightly increased human potency with a prolonged duration of action. [...] With compounds 76–78 it has been shown that fluorination of the 4-ethoxy group of escaline (70) can change the (psycho)pharmacological properties profoundly. While monofluorination causes loss of psychoactivity (compound 76), difluorination retains human potency (compound 77) and the trifluoroethoxy derivative 78 proved to be a long-lasting psychedelic with similar or slightly increased potency.
  3. ^abcdefghiKolaczynska KE, Luethi D, Trachsel D, Hoener MC, Liechti ME (2021)."Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines".Frontiers in Pharmacology.12 794254.doi:10.3389/fphar.2021.794254.PMC 8865417.PMID 35222010.
  4. ^abTrachsel D (2002). "Synthese von neuen (Phenylalkyl)aminen zur Untersuchung von Struktur-Aktivitätsbeziehungen, Mitteilung 1, Mescalin Derivate".Helvetica Chimica Acta.85 (9):3019–3026.doi:10.1002/1522-2675(200209)85:9<3019::AID-HLCA3019>3.0.CO;2-4.

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
TAAR1Tooltip Trace amine-associated receptor 1
Agonists
Endogenous
Exogenous
Antagonists
Inverse agonists
TAAR5Tooltip Trace amine-associated receptor 5
Agonists
Inverse agonists
Notes: (1) TAAR1 activity of ligands varies significantly between species. Some agents that are TAAR1 ligands in some species are not in other species. This navbox includes all TAAR1 ligands regardless of species. (2) See the individual pages for references, as well as theList of trace amines,TAAR, andTAAR1 pages.
See also:Receptor/signaling modulators
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Stub icon

Thishallucinogen-related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Trifluoroescaline&oldid=1317618731"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp